Showing results (121-130 of 133) with videos related to
Sort By:
Pageof 14
The Journal of Clinical Endocrinology and Metabolism|October 5, 2002
The pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient adultsD M Cook, B M K Biller, M L Vance, et al.Frontiers in Aging Neuroscience|March 1, 2024
IGF1R deficiency in vascular smooth muscle cells impairs myogenic autoregulation and cognition in miceLauren R Miller, Marisa A Bickel, Stefano Tarantini, et al.European Journal of Endocrinology|December 3, 2005
Consensus statement: medical management of acromegalyS Melmed, F Casanueva, F Cavagnini, et al.Lancet (London, England)|July 16, 1983
Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiencyJ L Borges, R M Blizzard, M C Gelato, et al.The Journal of Clinical Endocrinology and Metabolism|September 24, 1998
Octreotide as primary therapy for acromegalyC B Newman, S Melmed, A George, et al.Journal of Endocrinological Investigation|April 2, 2004
Diagnosis and treatment of acromegaly complicationsA Giustina, F F Casanueva, F Cavagnini, et al.Journal of the American Chemical Society|July 23, 2008
Near-edge X-ray absorption fine structure spectroscopy of diamondoid thiol monolayers on goldTrevor M Willey, Jason D Fabbri, Jonathan R I Lee, et al.The Journal of Clinical Endocrinology and Metabolism|December 13, 2003
Diagnosis and complications of Cushing's syndrome: a consensus statementG Arnaldi, A Angeli, A B Atkinson, et al.The Journal of Clinical Endocrinology and Metabolism|April 17, 2008
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statementB M K Biller, A B Grossman, P M Stewart, et al.Lancet (London, England)|December 6, 2001
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonistA J van der Lely, R K Hutson, P J Trainer, et al.Pageof 14